Higher tumor mass and lower adipose mass are associated with colon‑26 adenocarcinoma‑induced cachexia in male, female and ovariectomized mice

Banh,Taylor; Snoke,Deena; Cole,Rachel   M.; Angelotti,Austin; Schnell,Patrick   M.; Belury,Martha   A.

doi:10.3892/or.2019.7079

Higher tumor mass and lower adipose mass are associated with colon‑26 adenocarcinoma‑induced cachexia in male, female and ovariectomized mice

Authors:
- Taylor Banh
- Deena Snoke
- Rachel M. Cole
- Austin Angelotti
- Patrick M. Schnell
- Martha A. Belury
View Affiliations

Affiliations: Interdisciplinary PhD Program in Nutrition, The Graduate School, The Ohio State University, Columbus, OH 43201, USA, Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH 43201, USA, Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, OH 43201, USA
Published online on: March 20, 2019 https://doi.org/10.3892/or.2019.7079
Pages: 2909-2918

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cachexia is responsible for nearly 20% of all cancer‑related deaths, yet effective therapies to prevent or treat the disease are lacking. Clinical studies have shown that male patients lose weight at a faster rate than females. Additionally, an ‘obesity paradox’ may exist where excess adiposity may confer survival to patients with cancer cachexia. To further explore these phenomena, the aim of this study was to evaluate the role of changes of adipose tissue mass, sex status, and tumor mass on outcomes of male, female and ovariectomized (OVX) mice with C‑26 adenocarcinoma‑induced cachexia. We used EchoMRI to assess body composition and grip strength to measure muscle function. Body weights and food intake were measured daily. Mice were euthanized 19 days post‑inoculation. Post‑necropsy, muscle fiber cross‑sectional areas were quantified and real‑time PCR was performed for genes relating to proteolysis. Survival curve, correlation and multiple linear regression analyses were performed to identify predictors of cachexia. Female and OVX tumor mice developed cachexia similarly to males, as evidenced by loss of skeletal and adipose masses, decreased grip strength, and increased proteolytic gene expression. Notably, female and OVX tumor mice had earlier onset of cachexia (≥5% weight loss) than male tumor mice. Larger tumor mass and lower adipose mass were the strongest predicting factors for increased severity of cachexia, regardless of sex or ovariectomy status. These results indicated that the impact of sex status may be subtle in comparison to the predictive effect of tumor and adipose mass in mice with C‑26‑induced cachexia.

View Figures

View References

1	Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al: Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 12:489–495. 2011. View Article : Google Scholar : PubMed/NCBI
2	Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer. 2:862–871. 2002. View Article : Google Scholar : PubMed/NCBI
3	Fouladiun M, Korner U, Bosaeus I, Danaeryd P, Hyltander A and Lundholm KG: Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones. Cancer. 103:2189–2198. 2005. View Article : Google Scholar : PubMed/NCBI
4	Dahlman I, Mejhert N, Linder K, Agustsson T, Mutch DM, Kulyte A, Isaksson B, Permert J, Petrovic N, Nedergaard J, et al: Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer. 102:1541–1548. 2010. View Article : Google Scholar : PubMed/NCBI
5	Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, Koff D, Moran GR and Mourtzakis M: Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: The relationship with diabetes and anaemia. Br J Nutr. 109:302–312. 2013. View Article : Google Scholar : PubMed/NCBI
6	Ebadi M and Mazurak VC: Evidence and mechanisms of fat depletion in cancer. Nutrients. 6:5280–5297. 2014. View Article : Google Scholar : PubMed/NCBI
7	Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, Isaksson B, Permert J and Arner P: Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 67:5531–5537. 2007. View Article : Google Scholar : PubMed/NCBI
8	Kalantar-Zadeh K, Horwich TB, Oreopoulous A, Kovesdy CP, Younessi H, Anker SD and Morley JE: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 10:433–442. 2007. View Article : Google Scholar : PubMed/NCBI
9	Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB and Baracos VE: Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 31:1539–1547. 2013. View Article : Google Scholar : PubMed/NCBI
10	Nakamura N, Hara T, Shibata Y, Matsumoto T, Nakamura H, Ninomiya S, Kito Y, Kitagawa J, Kanemura N and Goto N: Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Ann Hematol. 94:2043–2053. 2015. View Article : Google Scholar : PubMed/NCBI
11	Kim EY, Kim YS, Park I, Ahn HK, Cho EK and Jeong YM: Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer. J Thorac Oncol. 10:1795–1799. 2015. View Article : Google Scholar : PubMed/NCBI
12	Wallengren O, Iresjo BM, Lundholm K and Bosaeus I: Loss of muscle mass in the end of life in patients with advanced cancer. Support Care Cancer. 23:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
13	Masel EK, Berghoff AS, Fureder LM, Heicappell P, Schlieter F, Widhalm G, Gatterbauer B, Dieckmann U, Birner P, Bartsch R, et al: Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients. Eur J Cancer Care (Engl). 26:62017. View Article : Google Scholar
14	Karastergiou K, Smith SR, Greenberg AS and Fried SK: Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 3:132012. View Article : Google Scholar : PubMed/NCBI
15	Carr MC: The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 88:2404–2411. 2003. View Article : Google Scholar : PubMed/NCBI
16	Aulino P, Perardi E, Cardillo VM, Rizzuto E, Perniconi B, Ramina C, Padula F, Spugnini EP, Baldi A, Faiola F, et al: Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 10:3632010. View Article : Google Scholar : PubMed/NCBI
17	Strassmann G, Fong M, Kenney JS and Jacob CO: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest. 89:1681–1684. 1992. View Article : Google Scholar : PubMed/NCBI
18	Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev. 89:381–410. 2009. View Article : Google Scholar : PubMed/NCBI
19	Murphy KT, Chee A, Trieu J, Naim T and Lynch GS: Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 5:533–545. 2012. View Article : Google Scholar : PubMed/NCBI
20	Tian M, Asp ML, Nishijima Y and Belury MA: Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. Int J Oncol. 39:1321–1326. 2011.PubMed/NCBI
21	Johns N, Stephens NA and Fearon KC: Muscle wasting in cancer. Int J Biochem Cell Biol. 45:2215–2229. 2013. View Article : Google Scholar : PubMed/NCBI
22	Kliewer KL, Ke JY, Tian M, Cole RM, Andridge RR and Belury MA: Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol Ther. 16:886–897. 2015. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Silva KA, Dong J, Dong Y, Dong Y, Schor N, Tweardy DJ, Zhang L and Mitch WE: Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem. 290:11177–11187. 2015. View Article : Google Scholar : PubMed/NCBI
25	Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, et al: Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 142:531–543. 2010. View Article : Google Scholar : PubMed/NCBI
26	Asp ML, Tian M, Kliewer KL and Belury MA: Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia. Cancer Biol Ther. 12:957–965. 2011. View Article : Google Scholar : PubMed/NCBI
27	Talbert EE, Metzger GA, He WA and Guttridge DC: Modeling human cancer cachexia in colon 26 tumor-bearing adult mice. J Cachexia Sarcopenia Muscle. 5:321–328. 2014. View Article : Google Scholar : PubMed/NCBI
28	Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD and Palin MF: Adiponectin action from head to toe. Endocrine. 37:11–32. 2010. View Article : Google Scholar : PubMed/NCBI
29	Hetzler KL, Hardee JP, LaVoie HA, Murphy EA and Carson JA: Ovarian function's role during cancer cachexia progression in the female mouse. Am J Physiol Endocrinol Metab. 312:E447–E459. 2017. View Article : Google Scholar : PubMed/NCBI
30	Palomares MR, Sayre JW, Shekar KC, Lillington LM and Chelebowski RT: Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer. 78:2119–2126. 1996. View Article : Google Scholar : PubMed/NCBI
31	Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, et al: Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 23:1699–1708. 2015. View Article : Google Scholar : PubMed/NCBI
32	Stephens NA, Gray C, MacDonald AJ, Tan BH, Gallagher IJ, Skipworth RJ, Ross JA, Fearon KC and Greig CA: Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr. 31:499–505. 2012. View Article : Google Scholar : PubMed/NCBI
33	Cosper PF and Leinwand LA: Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res. 71:1710–1720. 2011. View Article : Google Scholar : PubMed/NCBI
34	Hetzler KL, Hardee JP, Puppa MJ, Narsale AA, Sato S, Davis JM and Carson JA: Sex differences in the relationship of IL-6 signaling to cancer cachexia progression. Biochim Biophys Acta. 1852:816–825. 2015. View Article : Google Scholar : PubMed/NCBI
35	McGuire WL, Horwitz KB, Chamness GC and Zava DT: A physiological role for estrogen and progesterone in breast cancer. J Steroid Biochem. 7:875–882. 1976. View Article : Google Scholar : PubMed/NCBI
36	Richmond A and Su Y: Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech. 1:78–82. 2008. View Article : Google Scholar : PubMed/NCBI